{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T13:54:23Z","timestamp":1794405263948,"version":"4.9.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.clinbiochem.2024.110857","type":"journal-article","created":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T17:57:22Z","timestamp":1732384642000},"page":"110857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Cardiac biomarkers and CT coronary angiography for the assessment of coronary heart disease"],"prefix":"10.1016","volume":"135","author":[{"given":"Gard Mikael S\u00e6le","family":"Myrmel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Wereski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"Karaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasir","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin Moberg","family":"Aakre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas L.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Ringdal","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1 Pt 2","key":"10.1016\/j.clinbiochem.2024.110857_b0005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0002-8703(91)90861-B","article-title":"Cardiovascular disease risk profiles","volume":"121","author":"Anderson","year":"1991","journal-title":"Am Heart J."},{"key":"10.1016\/j.clinbiochem.2024.110857_b0010","article-title":"Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study","volume":"357","author":"Hippisley-Cox","year":"2017","journal-title":"Bmj."},{"issue":"11","key":"10.1016\/j.clinbiochem.2024.110857_b0015","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","article-title":"Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project","volume":"24","author":"Conroy","year":"2003","journal-title":"Eur Heart J."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110857_b0020","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ahj.2010.05.002","article-title":"Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers","volume":"160","author":"Eggers","year":"2010","journal-title":"Am Heart J."},{"issue":"7","key":"10.1016\/j.clinbiochem.2024.110857_b0025","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jama.284.7.835","article-title":"The TIMI risk score for unstable angina\/non-ST elevation MI: A method for prognostication and therapeutic decision making","volume":"284","author":"Antman","year":"2000","journal-title":"Jama."},{"issue":"24","key":"10.1016\/j.clinbiochem.2024.110857_b0030","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM197906143002402","article-title":"Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease","volume":"300","author":"Diamond","year":"1979","journal-title":"N Engl J Med."},{"key":"10.1016\/j.clinbiochem.2024.110857_b0035","doi-asserted-by":"crossref","first-page":"e3485","DOI":"10.1136\/bmj.e3485","article-title":"Prediction model to estimate presence of coronary artery disease: retrospective pooled analysis of existing cohorts","volume":"344","author":"Genders","year":"2012","journal-title":"Bmj."},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110857_b0040","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/eurpub\/ckx216","article-title":"Current and future cardiovascular disease risk assessment in the European Union: an international comparative study","volume":"28","author":"Mossakowska","year":"2018","journal-title":"Eur J Public Health."},{"issue":"3","key":"10.1016\/j.clinbiochem.2024.110857_b0045","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J."},{"issue":"3","key":"10.1016\/j.clinbiochem.2024.110857_b0050","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jcct.2020.11.001","article-title":"SCCT 2021 Expert Consensus Document on Coronary Computed Tomographic Angiography: A Report of the Society of Cardiovascular Computed Tomography","volume":"15","author":"Narula","year":"2021","journal-title":"J Cardiovasc Comput Tomogr."},{"issue":"14","key":"10.1016\/j.clinbiochem.2024.110857_b0055","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"42","author":"Collet","year":"2021","journal-title":"Eur Heart J."},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110857_b0060","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jacc.2018.05.027","article-title":"Coronary Calcium Score and Cardiovascular Risk","volume":"72","author":"Greenland","year":"2018","journal-title":"J Am Coll Cardiol."},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110857_b0065","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s11239-022-02709-2","article-title":"Biomarkers associated with coronary high-risk plaques","volume":"54","author":"Nakajima","year":"2022","journal-title":"J Thromb Thrombolysis."},{"issue":"5","key":"10.1016\/j.clinbiochem.2024.110857_b0070","doi-asserted-by":"crossref","first-page":"e010259","DOI":"10.1161\/CIRCHEARTFAILURE.122.010259","article-title":"Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial","volume":"16","author":"Jering","year":"2023","journal-title":"Circ Heart Fail."},{"issue":"10","key":"10.1016\/j.clinbiochem.2024.110857_b0075","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1097\/00004872-200310000-00002","article-title":"C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders?","volume":"21","author":"Rattazzi","year":"2003","journal-title":"J Hypertens."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110857_b0080","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1373\/clinchem.2008.108886","article-title":"The evolving role of C-reactive protein in atherothrombosis","volume":"55","author":"Devaraj","year":"2009","journal-title":"Clin Chem."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110857_b0085","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1373\/clinchem.2016.255174","article-title":"Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease","volume":"63","author":"Wollert","year":"2017","journal-title":"Clin Chem."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110857_b0090","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4049\/jimmunol.2200641","article-title":"Emerging Roles of Growth Differentiation Factor 15 in Immunoregulation and Pathogenesis","volume":"210","author":"Reyes","year":"2023","journal-title":"J Immunol."},{"issue":"25","key":"10.1016\/j.clinbiochem.2024.110857_b0095","doi-asserted-by":"crossref","first-page":"e1162","DOI":"10.1161\/CIR.0000000000000638","article-title":"Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology","volume":"139","author":"Lloyd-Jones","year":"2019","journal-title":"Circulation."},{"issue":"8","key":"10.1016\/j.clinbiochem.2024.110857_b0100","doi-asserted-by":"crossref","first-page":"e1343","DOI":"10.1016\/S2214-109X(24)00210-9","article-title":"Risk estimation for the primary prevention of cardiovascular disease: considerations for appropriate risk prediction model selection","volume":"12","author":"van Daalen","year":"2024","journal-title":"Lancet Glob Health."},{"issue":"30","key":"10.1016\/j.clinbiochem.2024.110857_b0105","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/eurheartj\/ehw172","article-title":"Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium","volume":"37","author":"Blankenberg","year":"2016","journal-title":"Eur Heart J."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110857_b0110","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.annepidem.2012.11.004","article-title":"Troponin T, B-type natriuretic peptide, C-reactive protein, and cause-specific mortality","volume":"23","author":"Oluleye","year":"2013","journal-title":"Ann Epidemiol."},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110857_b0115","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/STROKEAHA.111.000173","article-title":"Troponin T, N-terminal pro-B-type natriuretic peptide, and incidence of stroke: the atherosclerosis risk in communities study","volume":"44","author":"Folsom","year":"2013","journal-title":"Stroke."},{"issue":"13","key":"10.1016\/j.clinbiochem.2024.110857_b0120","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1161\/CIRCULATIONAHA.112.129437","article-title":"Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study","volume":"126","author":"Wang","year":"2012","journal-title":"Circulation."},{"issue":"15","key":"10.1016\/j.clinbiochem.2024.110857_b0125","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/01.CIR.101.15.1767","article-title":"Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men","volume":"101","author":"Ridker","year":"2000","journal-title":"Circulation."},{"issue":"15","key":"10.1016\/j.clinbiochem.2024.110857_b0130","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1136\/heartjnl-2015-309136","article-title":"High-sensitivity cardiac troponin I and incident coronary heart disease among asymptomatic older adults","volume":"102","author":"Iribarren","year":"2016","journal-title":"Heart."},{"issue":"13","key":"10.1016\/j.clinbiochem.2024.110857_b0135","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1161\/CIRCULATIONAHA.110.005264","article-title":"Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study","volume":"123","author":"Saunders","year":"2011","journal-title":"Circulation."},{"issue":"5","key":"10.1016\/j.clinbiochem.2024.110857_b0140","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jacc.2017.05.062","article-title":"High-Sensitivity Cardiac Troponin Concentration and Risk of First-EverCardiovascular Outcomes in154,052 Participants","volume":"70","author":"Willeit","year":"2017","journal-title":"J Am Coll Cardiol."},{"issue":"10289","key":"10.1016\/j.clinbiochem.2024.110857_b0145","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/S0140-6736(21)00520-1","article-title":"IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"397","author":"Ridker","year":"2021","journal-title":"Lancet."},{"issue":"25","key":"10.1016\/j.clinbiochem.2024.110857_b0150","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.jacc.2016.10.020","article-title":"High-Sensitivity Cardiac Troponin, StatinTherapy, and Risk of CoronaryHeartDisease","volume":"68","author":"Ford","year":"2016","journal-title":"J Am Coll Cardiol."},{"issue":"21","key":"10.1016\/j.clinbiochem.2024.110857_b0155","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med."},{"issue":"34","key":"10.1016\/j.clinbiochem.2024.110857_b0160","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"Visseren","year":"2021","journal-title":"European Heart Journal."},{"issue":"10151","key":"10.1016\/j.clinbiochem.2024.110857_b0165","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(18)31923-8","article-title":"High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial","volume":"392","author":"Shah","year":"2018","journal-title":"Lancet."},{"issue":"19","key":"10.1016\/j.clinbiochem.2024.110857_b0170","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/CIRCULATIONAHA.119.042866","article-title":"High-Sensitivity Troponin and the Application of Risk Stratification Thresholds in Patients With Suspected Acute Coronary Syndrome","volume":"140","author":"Bularga","year":"2019","journal-title":"Circulation."},{"issue":"23","key":"10.1016\/j.clinbiochem.2024.110857_b0175","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1136\/heartjnl-2019-316242","article-title":"Implementing an early rule-out pathway for acute myocardial infarction in clinical practice","volume":"107","author":"Lowry","year":"2021","journal-title":"Heart."},{"issue":"23","key":"10.1016\/j.clinbiochem.2024.110857_b0180","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1161\/CIRCULATIONAHA.120.052380","article-title":"High-Sensitivity Cardiac Troponin on Presentation to Rule Out Myocardial Infarction: A Stepped-Wedge Cluster Randomized Controlled Trial","volume":"143","author":"Anand","year":"2021","journal-title":"Circulation."},{"issue":"9","key":"10.1016\/j.clinbiochem.2024.110857_b0185","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/eurheartj\/eht530","article-title":"Biomarkers and acute coronary syndromes: an update","volume":"35","author":"Mueller","year":"2014","journal-title":"Eur Heart J."},{"issue":"18","key":"10.1016\/j.clinbiochem.2024.110857_b0190","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1093\/eurheartj\/ehs154","article-title":"How to use high-sensitivity cardiac troponins in acute cardiac care","volume":"33","author":"Thygesen","year":"2012","journal-title":"Eur Heart J."},{"issue":"18","key":"10.1016\/j.clinbiochem.2024.110857_b0195","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM199610313351802","article-title":"Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes","volume":"335","author":"Antman","year":"1996","journal-title":"N Engl J Med."},{"issue":"34","key":"10.1016\/j.clinbiochem.2024.110857_b0200","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1093\/eurheartj\/ehu188","article-title":"Direct comparison of high-sensitivity-cardiac troponin I vs. T for the early diagnosis of acute myocardial infarction","volume":"35","author":"Rubini Gimenez","year":"2014","journal-title":"Eur Heart J."},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110857_b0205","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/eurheartj\/eht218","article-title":"Risk stratification in patients with acute chest pain using three high-sensitivity cardiac troponin assays","volume":"35","author":"Haaf","year":"2014","journal-title":"Eur Heart J."},{"issue":"12","key":"10.1016\/j.clinbiochem.2024.110857_b0210","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.jacc.2012.12.026","article-title":"Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease","volume":"61","author":"Omland","year":"2013","journal-title":"J Am Coll Cardiol."},{"issue":"24","key":"10.1016\/j.clinbiochem.2024.110857_b0215","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1161\/CIRCULATIONAHA.118.038529","article-title":"Cardiac Troponin T and Troponin I in the General Population","volume":"139","author":"Welsh","year":"2019","journal-title":"Circulation."},{"issue":"15","key":"10.1016\/j.clinbiochem.2024.110857_b0220","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1136\/heartjnl-2012-301635","article-title":"The prognostic value of high sensitivity troponin T 7 weeks after an acute coronary syndrome","volume":"98","author":"Ang","year":"2012","journal-title":"Heart."},{"key":"10.1016\/j.clinbiochem.2024.110857_b0225","doi-asserted-by":"crossref","DOI":"10.1093\/clinchem\/hvae110","article-title":"Diagnosing Myocardial Injury in an Acute Chest Pain Cohort; Long-Term Prognostic Implications of Cardiac Troponin T and I","author":"Saeed","year":"2024","journal-title":"Clinical Chemistry."},{"issue":"22","key":"10.1016\/j.clinbiochem.2024.110857_b0230","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1136\/heartjnl-2019-315084","article-title":"Convalescent troponin and cardiovascular death following acute coronary syndrome","volume":"105","author":"Adamson","year":"2019","journal-title":"Heart."},{"issue":"14","key":"10.1016\/j.clinbiochem.2024.110857_b0235","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","volume":"42","author":"Collet","year":"2020","journal-title":"European Heart Journal."},{"issue":"14","key":"10.1016\/j.clinbiochem.2024.110857_b0240","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1056\/NEJMoa011053","article-title":"The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes","volume":"345","author":"de Lemos","year":"2001","journal-title":"N Engl J Med."},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110857_b0245","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jacc.2009.03.056","article-title":"Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome","volume":"54","author":"Eggers","year":"2009","journal-title":"J Am Coll Cardiol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110857_b0250","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jacc.2010.01.060","article-title":"Prognostic value of mid-regional pro-adrenomedullin levels taken on admission and discharge in non-ST-elevation myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) II study","volume":"56","author":"Dhillon","year":"2010","journal-title":"J Am Coll Cardiol."},{"issue":"8","key":"10.1016\/j.clinbiochem.2024.110857_b0255","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1161\/CIRCULATIONAHA.106.650846","article-title":"Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome","volume":"115","author":"Wollert","year":"2007","journal-title":"Circulation."},{"issue":"15","key":"10.1016\/j.clinbiochem.2024.110857_b0260","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/01.CIR.0000015464.18023.0A","article-title":"Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide","volume":"105","author":"Sabatine","year":"2002","journal-title":"Circulation."},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110857_b0265","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCULATIONAHA.106.641936","article-title":"Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes","volume":"114","author":"O'Donoghue","year":"2006","journal-title":"Circulation."},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110857_b0270","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/eurheartj\/ehu178","article-title":"Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study","volume":"36","author":"M\u00f6ckel","year":"2015","journal-title":"Eur Heart J."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110857_b0275","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ahj.2013.03.014","article-title":"Comparison of the performances of cardiac troponins, including sensitive assays, and copeptin in the diagnostic of acute myocardial infarction and long-term prognosis between women and men","volume":"166","author":"Balmelli","year":"2013","journal-title":"Am Heart J."},{"key":"10.1016\/j.clinbiochem.2024.110857_b0280","doi-asserted-by":"crossref","DOI":"10.1093\/clinchem\/hvad015","article-title":"Growth Differentiation Factor 15: A Prognostic Marker in Patients with Acute Chest Pain without Acute Myocardial Infarction","author":"Myrmel","year":"2023","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinbiochem.2024.110857_b0285","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2023-323260","article-title":"Prognostic value of growth differentiation factor-15 3 months after an acute chest pain admission","author":"Myrmel","year":"2023","journal-title":"Heart"},{"issue":"7","key":"10.1016\/j.clinbiochem.2024.110857_b0290","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199408183310701","article-title":"The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina","volume":"331","author":"Liuzzo","year":"1994","journal-title":"N Engl J Med."},{"issue":"12","key":"10.1016\/j.clinbiochem.2024.110857_b0295","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1373\/clinchem.2007.090613","article-title":"Risk stratification for heart failure and death in an acute coronary syndrome population using inflammatory cytokines and N-terminal pro-brain natriuretic peptide","volume":"53","author":"Kavsak","year":"2007","journal-title":"Clin Chem."},{"issue":"5\u20136","key":"10.1016\/j.clinbiochem.2024.110857_b0300","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.clinbiochem.2006.10.025","article-title":"Elevated C-reactive protein in acute coronary syndrome presentation is an independent predictor of long-term mortality and heart failure","volume":"40","author":"Kavsak","year":"2007","journal-title":"Clin Biochem."},{"issue":"3","key":"10.1016\/j.clinbiochem.2024.110857_b0305","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/ijcp.12245","article-title":"Interleukin-6 as a predictor of cardiovascular events in troponin-negative non-ST elevation acute coronary syndrome patients","volume":"68","author":"Garc\u00eda-Salas","year":"2014","journal-title":"Int J Clin Pract."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110857_b0310","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/clinchem\/hvab225","article-title":"Diagnostic Performance of Novel Troponin Algorithms for the Rule-Out of Non-ST-Elevation Acute Coronary Syndrome","volume":"68","author":"Tjora","year":"2022","journal-title":"Clin Chem."},{"key":"10.1016\/j.clinbiochem.2024.110857_b0315","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.amjcard.2022.03.001","article-title":"Relation of High-Sensitivity Cardiac Troponin I and Obstructive Coronary Artery Disease in Patients Without Acute Myocardial Infarction","volume":"173","author":"Mohebi","year":"2022","journal-title":"Am J Cardiol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110857_b0320","doi-asserted-by":"crossref","first-page":"e004227","DOI":"10.1161\/CIRCOUTCOMES.117.004227","article-title":"High-Sensitivity Cardiac Troponin I and the Diagnosis of Coronary Artery Disease in Patients With Suspected Angina Pectoris","volume":"11","author":"Adamson","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes."},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110857_b0325","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jacc.2023.05.046","article-title":"High-Sensitivity Cardiac Troponin for RiskAssessment in Patients With ChronicCoronary Artery Disease","volume":"82","author":"Wereski","year":"2023","journal-title":"J Am Coll Cardiol."},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110857_b0330","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007975","article-title":"Single-Molecule Counting of High-Sensitivity Troponin I in Patients Referred for Diagnostic Angiography: Results From the CASABLANCA (Catheter Sampled Blood Archive in Cardiovascular Diseases) Study","volume":"7","author":"McCarthy","year":"2018","journal-title":"J Am Heart Assoc."},{"issue":"3","key":"10.1016\/j.clinbiochem.2024.110857_b0335","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jacc.2018.10.065","article-title":"Single-Molecule hsTnI and Short-Term Risk in Stable Patients With Chest Pain","volume":"73","author":"Januzzi","year":"2019","journal-title":"J Am Coll Cardiol."},{"issue":"17","key":"10.1016\/j.clinbiochem.2024.110857_b0340","doi-asserted-by":"crossref","first-page":"e024516","DOI":"10.1161\/JAHA.121.024516","article-title":"Association of High-Sensitivity Troponin T and I Blood Concentrations With All-Cause Mortality and Cardiovascular Outcome in Stable Patients-Results From the INTERCATH Cohort","volume":"11","author":"Bay","year":"2022","journal-title":"J Am Heart Assoc."},{"issue":"7","key":"10.1016\/j.clinbiochem.2024.110857_b0345","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jacc.2017.06.030","article-title":"Biomarker-Based Risk Model to PredictCardiovascular Mortality in PatientsWithStableCoronaryDisease","volume":"70","author":"Lindholm","year":"2017","journal-title":"J Am Coll Cardiol."},{"issue":"3","key":"10.1016\/j.clinbiochem.2024.110857_b0350","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.carrev.2014.02.003","article-title":"Comparative prognostic value of low-density lipoprotein cholesterol and C-reactive protein in patients with stable coronary artery disease treated with percutaneous coronary intervention and chronic statin therapy","volume":"15","author":"Ndrepepa","year":"2014","journal-title":"Cardiovasc Revasc Med."},{"issue":"24","key":"10.1016\/j.clinbiochem.2024.110857_b0355","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1093\/eurheartj\/ehl362","article-title":"Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study","volume":"27","author":"Sinning","year":"2006","journal-title":"Eur Heart J."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110857_b0360","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjcard.2006.01.045","article-title":"Interleukin-6 and the risk of future cardiovascular events in patients with angina pectoris and\/or healed myocardial infarction","volume":"98","author":"Fisman","year":"2006","journal-title":"Am J Cardiol."},{"issue":"24","key":"10.1016\/j.clinbiochem.2024.110857_b0365","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1093\/eurheartj\/ehq322","article-title":"Multiple marker approach to risk stratification in patients with stable coronary artery disease","volume":"31","author":"Schnabel","year":"2010","journal-title":"Eur Heart J."},{"issue":"19","key":"10.1016\/j.clinbiochem.2024.110857_b0370","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in Patients with Chronic Coronary Disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med."},{"issue":"12","key":"10.1016\/j.clinbiochem.2024.110857_b0375","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med."},{"issue":"15","key":"10.1016\/j.clinbiochem.2024.110857_b0380","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.jacc.2021.02.049","article-title":"Randomized Trial of Interleukin-6 Receptor Inhibition in Patients WithAcute ST-Segment Elevation Myocardial Infarction","volume":"77","author":"Broch","year":"2021","journal-title":"J Am Coll Cardiol."},{"issue":"30","key":"10.1016\/j.clinbiochem.2024.110857_b0385","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1093\/eurheartj\/ehw171","article-title":"Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial","volume":"37","author":"Kleveland","year":"2016","journal-title":"Eur Heart J."},{"issue":"7","key":"10.1016\/j.clinbiochem.2024.110857_b0390","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jacc.2021.06.019","article-title":"Coronary Computed Tomographic Angiography for Complete Assessment of Coronary Artery Disease","volume":"78","author":"Serruys","year":"2021","journal-title":"Journal of the American College of Cardiology."},{"issue":"10","key":"10.1016\/j.clinbiochem.2024.110857_b0395","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa1805971","article-title":"Coronary CT Angiography and 5-Year Risk of Myocardial Infarction","volume":"379","author":"Newby","year":"2018","journal-title":"N Engl J Med."},{"issue":"14","key":"10.1016\/j.clinbiochem.2024.110857_b0400","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMoa1415516","article-title":"Outcomes of anatomical versus functional testing for coronary artery disease","volume":"372","author":"Douglas","year":"2015","journal-title":"N Engl J Med."},{"issue":"8","key":"10.1016\/j.clinbiochem.2024.110857_b0405","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jacc.2006.08.064","article-title":"A Randomized Controlled Trial of Multi-Slice Coronary Computed Tomography for Evaluation of Acute Chest Pain","volume":"49","author":"Goldstein","year":"2007","journal-title":"Journal of the American College of Cardiology."},{"issue":"38","key":"10.1016\/j.clinbiochem.2024.110857_b0410","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC)","volume":"44","author":"Byrne","year":"2023","journal-title":"European Heart Journal."},{"issue":"20","key":"10.1016\/j.clinbiochem.2024.110857_b0415","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1016\/j.jacc.2019.09.027","article-title":"Initial Imaging-Guided Strategy VersusRoutine Care in Patients WithNon-ST-Segment Elevation Myocardial Infarction","volume":"74","author":"Smulders","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.clinbiochem.2024.110857_b0420","article-title":"Early computed tomography coronary angiography in patients with suspected acute coronary syndrome: randomised controlled trial","volume":"374","author":"Gray","year":"2021","journal-title":"Bmj."},{"issue":"18","key":"10.1016\/j.clinbiochem.2024.110857_b0425","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1161\/CIRCULATIONAHA.119.044720","article-title":"Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction: Results From the Multicenter SCOT-HEART Trial (Scottish Computed Tomography of the HEART)","volume":"141","author":"Williams","year":"2020","journal-title":"Circulation."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110857_b0430","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1148\/radiol.2015141648","article-title":"Automated Quantitative Plaque Burden from Coronary CT Angiography Noninvasively Predicts Hemodynamic Significance by using Fractional Flow Reserve in Intermediate Coronary Lesions","volume":"276","author":"Diaz-Zamudio","year":"2015","journal-title":"Radiology."},{"issue":"12","key":"10.1016\/j.clinbiochem.2024.110857_b0435","doi-asserted-by":"crossref","first-page":"e526","DOI":"10.1093\/ehjci\/jeac174","article-title":"Pericoronary fat attenuation index-a new imaging biomarker and its diagnostic and prognostic utility: a systematic review and meta-analysis","volume":"23","author":"Sagris","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging."},{"issue":"10151","key":"10.1016\/j.clinbiochem.2024.110857_b0440","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(18)31114-0","article-title":"Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data","volume":"392","author":"Oikonomou","year":"2018","journal-title":"Lancet."},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110857_b0445","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/ATVBAHA.109.200394","article-title":"The extent of coronary atherosclerosis is associated with increasing circulating levels of high sensitive cardiac troponin T","volume":"30","author":"Laufer","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"22","key":"10.1016\/j.clinbiochem.2024.110857_b0450","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1136\/heartjnl-2019-314892","article-title":"Clinical determinants of plasma cardiac biomarkers in patients with stable chest pain","volume":"105","author":"Bing","year":"2019","journal-title":"Heart."},{"issue":"9918","key":"10.1016\/j.clinbiochem.2024.110857_b0455","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(13)61754-7","article-title":"18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial","volume":"383","author":"Joshi","year":"2014","journal-title":"Lancet."},{"issue":"9","key":"10.1016\/j.clinbiochem.2024.110857_b0460","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/heartjnl-2022-321867","article-title":"Coronary low-attenuation plaque and high-sensitivity cardiac troponin","volume":"109","author":"Meah","year":"2023","journal-title":"Heart."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110857_b0465","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jcct.2020.03.005","article-title":"Association of high-risk coronary atherosclerosis at CCTA with clinical and circulating biomarkers: Insight from CAPIRE study","volume":"15","author":"Conte","year":"2021","journal-title":"J Cardiovasc Comput Tomogr."},{"issue":"8","key":"10.1016\/j.clinbiochem.2024.110857_b0470","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s10554-017-1098-y","article-title":"Association between interleukin-6 and the risk of cardiac events measured by coronary computed tomography angiography","volume":"33","author":"Zhao","year":"2017","journal-title":"Int J Cardiovasc Imaging."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110857_b0475","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.atherosclerosis.2015.04.811","article-title":"HDL cholesterol, leptin and interleukin-6 predict high risk coronary anatomy assessed by CT angiography in patients with stable chest pain","volume":"241","author":"Caselli","year":"2015","journal-title":"Atherosclerosis."},{"issue":"25","key":"10.1016\/j.clinbiochem.2024.110857_b0480","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1016\/j.jacc.2016.09.972","article-title":"The Emerging Role of Metabolomics intheDiagnosis and Prognosis of Cardiovascular Disease","volume":"68","author":"Ussher","year":"2016","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.clinbiochem.2024.110857_b0485","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ebiom.2018.12.033","article-title":"Predictive value of targeted proteomics for coronary plaque morphology in patients with suspected coronary artery disease","volume":"39","author":"Bom","year":"2019","journal-title":"EBioMedicine."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912024001516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912024001516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T14:51:44Z","timestamp":1736866304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912024001516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":97,"alternative-id":["S0009912024001516"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2024.110857","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac biomarkers and CT coronary angiography for the assessment of coronary heart disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2024.110857","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists.","name":"copyright","label":"Copyright"}],"article-number":"110857"}}